-February 26, 2008
Reports claim that a drug, which during the 1950's and 1960's malformed newborns, has proven to be a promising treatment for patients with mesothelioma.
The medication seems to be beneficial when used in combination with immune therapy.
Studies Conducted on Medication
Recent studies have revealed that after chemotherapy is administered, Thalidomide can prevent tumor regrowth in patients.
Phase two studies show that patients who are treated with Thalidomide combined with other mesothelioma medications have a 44 percent progressive disease patient response rates.
Side Effects of Thalidomide
Researchers say that Thalidomide has showed to be well received in patients.
However, as with most medication there are some common side effects linked to the medication, including:
• Dry mouth
• Paresthesias
• Constipation
Other Promising Treatments
Aside from Thalidomide, other new immune therapies are also proving to be effective in fighting mesothelioma.
According to researchers, treating mesothelioma as a bacteria or virus helps the body to use its immune system to prevent further tumor growth.
(Source: PR Web)
Do you know someone who is living with mesothelioma? If so, please contact us to speak with someone about the resources available to you.